eClinical Insights Launches eClinical Intelligence Platform - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
eClinical Insights Launches eClinical Intelligence Platform

Source: Company News Release

eClinical Insights, a leading-edge provider of cloud-based clinical trials software, announced today the launch of its eClinical Intelligence Platform. Built upon a first-in-class eClinical data hub that acquires and integrates data from any clinical system, and powered by a business analytics engine, the eClinical Insights platform delivers real-time clinical trial intelligence and workflow capabilities through a suite of cloud-based applications designed to help pharmaceutical, biotech, medical device, and contract research organizations improve the performance of their clinical trials through real-time data sharing and collaboration. 

 “With the average clinical trial using of 5-7 different clinical systems, one of the critical business challenges the industry faces today is turning these siloes of data into operational intelligence," said Peg Regan, President & CEO of eClinical Insights. “Our platform automatically leverages these disparate data into actionable information, and delivers it through an integrated suite of role-based applications. By eliminating operational blind spots, our technology platform empowers clinical research professionals with the visibility they need to make rapid, data-driven decisions."

The platform's open architecture includes a library of out-of-the-box interfaces to leading EDC technologies, enabling customers to leverage their existing technology investments as integrated components of the eClinical Insights platform. Delivered through a Software-as-a-Service (SaaS) subscription model, the platform includes a suite of cloud-based trial management applications that are available on per study basis, and can be turned on and off as needed, on both new and ongoing trials.

"We took a small data approach to solving a big data problem, and focused solely on the use of clinical trials data to optimize trial execution and collaboration," said Regan. "With a team that has decades of experience in clinical trials management, and unparalleled experience integrating data from EDC, IVR, ePRO, CTMS, and Central Laboratory systems, we had a unique vantage point from which to solve this challenge. We leveraged this experience in the development of a technology platform that delivers instant visibility across the diverse ecosystem of systems, service providers, and stakeholders of today's clinical trials."

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here